Arena Pharmaceuticals (ARNA) Reports a Q2 Loss; Comments on Outlook
Tweet Send to a Friend
Arena Pharmaceuticals (Nasdaq: ARNA) reports Q2 loss of $0.48, 1 cent better than the analyst estimate of ($0.49). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
